Navigation Links
Blood Glucose Testing and Diabetes Management - Dramatic Increase in the Incidence of Diabetes
Date:4/2/2013

DUBLIN, April 2, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Blood Glucose Testing and Diabetes Management" report to their offering.

     (Photo: http://photos.prnewswire.com/prnh/20130307/600769 )

There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease - sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes - the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet has resulted in skyrocketing rates of diabetes, particularly Type 2 diabetes, among adults across the world. As such, the global market for blood glucose testing products is undergoing a significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. Although the blood glucose testing segment of the in vitro diagnostics (IVD) industry is mature, certain segments of the market, such as home testing devices for diabetes management, will exhibit strong growth. What's more, non-invasive testing now represents a major new area for the application of IVD testing. Additionally, direct access testing - or over-the-counter testing, which allows consumers to order tests themselves without visiting a doctor`- has emerged as a strong force in the blood glucose testing segment.

The purpose of this TriMark Publications report is to describe the specific market segments for blood glucose testing and diabetes management. This study reviews all of the generally-accepted clinical analytical methods that are currently in use today for measuring serum or plasma or whole-blood glucose concentrations. Moreover, it examines clinical measurement devices, reagents and supplies as utilized in hospitals, clinics, doctor's offices and at-home care locations.

Key Topics Covered:

1. Overview

2. Diabetes

3. Market Analysis: Size, Growth, Share and Competitors

4. Glucose Diagnostic and Monitoring Recommendations

5. Glucose Testing Technology Platforms and Consumable Products

6. Glucose Testing Devices on the Market

7. Business Trends in Glucose Testing

8. Technology Trends

9. Company Profiles

Companies Mentioned:

- Abaxis, Inc.

- Abbott Laboratories

- ACON Laboratories

- AgaMatrix

- Alere

- All Medicus

- Amedica Biotech

- A. Menarini Diagnostics

- Apex Biotechnology Corporation

- ARKRAY

- Bayer

- B. Braun Melsungen

- Beckman Coulter

- Bionime

- Bio-Rad Laboratories, Inc.

- BioTex

- Calisto Medical

- Cambridge Sensors

- DexCom

- Diagnostic Devices/Prodigy Diabetes Care

- DiaSys

- Echo Therapeutics

- Entra Health Systems

- Fora Care

- Genesis Health Technologies

- GenExel-Sein

- GlucoPlus

- GluMetris

- GlySens

- Hainice Medical

- HemoCue (a Quest Diagnostics company)

- Home Diagnostics

- Infopia

- IN4 Technology

- International Techidyne Corporation (ITC)

- Instrumentation Laboratory Company

- i-Sens

- Johnson & Johnson

- Luminous Medical

- Medtronic

- Nipro Corporation

- Nova Biomedical

- OrSense

- Polymer Technology Systems

- Radiometer Medical

- Roche

- 77 Elektronika Kft.

- Siemens AG

- Smiths Group

- Stanbio Laboratory

- TaiDoc Technology

- Techno Medica Co., Ltd.

- US Diagnostics

- VeraLight

For more information visit http://www.researchandmarkets.com/research/j49msm/blood_glucose

Research and Markets
Laura Wood , Senior Manager,
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. China Cord Blood Corporation Received AABB Accreditation
2. Cellular Therapy and Cord Blood 2013 Market Report
3. Stem Cell / Regenerative Medicine & HSCT / Cord Blood Market Analysis in New Research Report at ReportsnReports.com
4. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
5. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
6. Dr. Carlos Szajnert, Announced today his Commitment to Further Educate his Patients on the Benefits of Cord Blood Stem Cells
7. UCLA researchers further refine NanoVelcro device to grab single cancer cells from blood
8. The Leukemia & Lymphoma Society: Impacting Blood Cancers and Beyond
9. China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2013 Financial Results
10. Cellular Therapy Market and Cord Blood Market 2013 Industry Research Report: MarketResearchReports.Biz
11. China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. presented ... expansion clinical trial for its lead drug candidate, AC0010, at the World Conference ... was to determine the safety, antitumor activity, and recommended phase II dosage of ...
(Date:12/7/2016)... Dec. 7, 2016 Neogen Corporation (NASDAQ: ... Dan Kephart as its chief science officer ... assume his responsibilities at Neogen effective Jan. 1. ... for the agribusiness unit of Thermo Fisher Scientific, as ... Life Technologies. His extensive industry experience also includes the ...
(Date:12/7/2016)... 2016  Nordion, a standalone business of Sterigenics ... today,s award by the United States Department of ... the Phase II cooperative agreement funding to GA ... University of Missouri Research Reactor Center (MURR ® ... establishment of a new, reliable supply of molybdenum ...
(Date:12/7/2016)... , Dec. 7, 2016  Vyriad Inc. announced ... to the company,s Board of Directors. "We ... we build our business and develop our oncolytic viruses ... therapy," said Stephen Russell , MD, PhD, CEO ... , share our vision and passion for making a ...
Breaking Biology Technology:
(Date:12/2/2016)... India , December 1, 2016 ... Authentication type (Fingerprint, Voice), Future Technology (Iris Recognition ... and Region - Global Forecast to 2021", published ... USD 442.7 Million in 2016, and is projected ... at a CAGR of 14.06%.      ...
(Date:11/30/2016)... 2016 Not many of us realize that we spend ? of our ... need to do it well. Inadequate sleep levels have been found to lead to ... and even cancer. Maybe now is the best time to rethink how ... to manage their sleep quality? Continue Reading ... ...
(Date:11/29/2016)... , Nov. 29, 2016 BioDirection, a privately ... products for the objective detection of concussion and other ... has successfully completed a meeting with the U.S. Food ... blood test Pre-Submission Package. During the meeting company representatives ... as a precursor to commencement of a planned pilot ...
Breaking Biology News(10 mins):